cells obtained from cell lines derived from MD lymphomas. All cell lines developed thus far from MD lymphomas consist of T lymphoblasts that carry the MDV genome and MATSA and are thus considered transforned by MDV. In virus-infected chickens, the cytotoxic effector cells have been detected in the spleen (27) as well as in the peripheral circulation (20) . Generally the levels of cytotoxic activity detectable in in vitro assays have been quite low. The nature of effector cells and the characteristics of their activity are not known.
The main objective in this study was to iden-46 tify the cytotoxic cell and to determine whether cytotoxic activity of effector cells could be influenced by pretreatment of target cells with neuraminidase. Similar modification of target cells has been shown to increase the expression of tumor antigens and thus augment the immune response against them (7, 24) .
MATERLALS AND METHODS Animals. Chickens were line 7 or F1 progeny of a cross between lines 7 and 15 being maintained at this laboratory (33) . The breeder flocks were held under specific-pathogen-free conditions and were free from natural infection with common poultry pathogens including herpesvirus of turkeys and MDV. All experimental chickens were held in Horsfal-Bauer-type cages under negative pressure from the day of hatch through the duration of the experiment.
New Zealand white rabbits were young adults obtained from a commercial source.
MDV. The JM strain of MDV was cloned as follows. Cell-free virus, extracted from the skin of MDVinfected line 7 chickens, was propagated in chicken kidney cell cultures under agar overlay. An individual, well-separated plaque was picked, and the progeny virus from this plaque was inoculated into 1-day-old chickens. Three weeks later, cell-free virus obtained from inoculated chickens was cloned again in chicken kidney cells. After a third similar cloning step, the virus was propagated in duck embryo fibroblast cells and stored at -196°C as cell-associated virus stock.
This stock, designated clone illS, had undergone 11 tissue culture passages before use in this study.
Effector cell preparation. Chickens were inoculated with 103 plaque-forming units of MDV at 6 days IMMUNITY TO TUMOR ANTIGEN IN MD of age. At the peak of the cytotoxic response (27), 7 to 8 days after inoculation, three to five infected and usually an equivalent number of uninfected control chickens were sampled, and their spleens were removed aseptically. Single spleen cell suspensions were made as described earlier (27) , except that the cell suspensions were clarified by being layered on a Ficoll-Hypaque gradient at specific gravity 1.09 and centrifuged for 10 min at 300 x g. Viable cells recovered from the interphase were used as effector cells. Surviving chickens from infected and uninfected control groups were raised under isolation for 3 to 4 weeks and were monitored for infection with MDV either by testing their sera for MDV antibody or by examining histological sections of peripheral nerves and gonads for lesions of MD. Infection with MDV could be consistently demonstrated in the inoculated groups but not in control groups.
Target cells. The cells of the MSB-1 line were used as targets. The MSB-1 line is a lymphoblastoid cell line developed by Akiyama and Kato (1) by propagating in vitro cells of a spleen lymphoma from a chicken affected with MD. The MSB-1 cells contain MATSA (34) and grow as suspension cultures as described in detail (1, 17) . For this study, we used cells from a single frozen stock held at -196°C (27) . Rapidly growing cells within 24 h of subculture were labeled with 100 mCi of Na25"CrO4 (specific activity, 229 mCi/mg; concentration, 1 mCi/ml; New England Nuclear, Boston, Mass.) for 45 min at 370C according to the procedures described in detail earlier (27) , except that at the end of the labeling period, cells were washed and used without further centrifugation on bovine serum albumin gradient.
In one experiment, cells of the TLT line were used as target cells. This line, provided by K. Nazerian, was derived from a lymphoid leukosis tumor in an outbred white leghorn chicken (32) . The TLT cells are lymphoblastoid in nature; they lack MATSA and are productively infected with ribonucleic acid tumor virus.
Cell-mediated cytotoxicity assay. The general procedure was as described previously (27) . Briefly, 0.1 ml of target cell suspension containing l05 5"Crlabeled MSB-1 cells was mixed with 0.1 ml of effector cell suspension containing 5 x 106 spleen cells (effector/target ratio of 50:1) in Microtest plates (3040 Microtest II, Falcon Plastics, Oxnard, Calif.) and incubated for 4 h at 370C in a 3 to 5% C02 atmosphere.
Two or three replicate wells were used for each effector cell preparation. At the end of 4 h the amount of 5"Cr released into the medium and total and spontaneous release were measured as described (27) . The percentage of specific release of 51Cr was calculated by the following formula: % specific release = fonic acid] buffer + 100 U of penicillin and 100 ag of streptomycin per ml). Each sample was tested in duplicate tubes. A 0.1-ml portion of serum dilution was mixed with 0.1 ml of target cell suspension containing 2 x 105 51Cr-labeled target cells. To this mixture was added 0.2 ml of an appropriate dilution (in Veronal buffer) of guinea pig complement (Difco Laboratories, Detroit, Mich., control no. 632753). The lyophilized complement was reconstituted according to the manufacturer's directions and absorbed once for 30 min at 40C with approximately 1/20 (vol/vol) of normal chicken lymphocytes. The optimum concentration of complement was predetermined in a homologous antigen-antibody reaction in the 5"Cr release assay.
The target cell-antibody-complement mixture was held at 370C for 45 to 60 min. At the end of incubation, 1.1 ml of cold Dulbecco phosphate-buffered saline (1.lx concentration containing 2% fetal bovine serum and 100 U of penicillin and 100,ug of streptomycin per ml, adjusted to pH 7.4 with 1 N NaOH) was added to each tube. The tubes were centrifuged at 700 x g for 5 min, and 1.0-ml portions of the supernatant fluid were carefully removed without disturbing the pellet and counted for gamma emission in a Beckman 300 gamma counter (Beckman Instruments Inc., Irvine, Calif). Counts per minute were averaged for each sample. Controls in each test consisted of target cells mixed with (i) preimmune serum and complement; (ii) complement without serum; (iii) medium alone (spontaneous release); and (iv) Triton X-100 detergent (maximum release). Generally, less than 10% of the total releasable isotope was recovered in the medium in controls (i), (ii), and (iii) above. The percentage of specific release was determined as follows:
% specific release = cpm in test sample in complement control maximum releasable cpm -cpm in complement control x 100
Antisera. Antithymocyte and anti-bursa cell sera were prepared by a similar procedure; two rabbits per cell type were used. Preimmunization serum samples from rabbits lacked anti-complementary activity.
Thymus and bursa tissues were removed from 3-week-old chickens of line 72. The age of donor chickens was considered critical because at 3 weeks, crosscontamination of thymus and bursa is minimal (2, 12) . Single-cell suspensions prepared as described earlier (27) In experiment 2 (Table 2) , effector cell preparations from seven chickens were examined.
Each preparation was reacted simultaneously with target cells pretreated with varying concentrations of VCN. The cytotoxic activity against untreated target cells ranged from 5.7 to 30.4%. This activity could be enhanced by pretreating target cells with VCN, although the level of enhancement by different preparations of effector cells varied widely. In experiment 2, the average increase in cytotoxic activity by using VCN-treated target cells was significant (P < 0.01). All doses of VCN used enhanced cytotoxicity, and differences in enhancement levels between doses of VCN were not significant (P > (Table 4) . DISCUSSION The process of tumorigenesis in MD is not entirely clear. Because a certain proportion of lymphoma cells contain MATSA (21, 34) , lymphomas are most likely initiated by cellular transformation by MDV. The transformed foci may recruit other, normal lymphoid cells that may possibly engage in immunological reactions against the transformed cells.
The identity of the transformed cells in vivo is not unequivocally proved, although circumstantial evidence strongly suggests that the transformed fraction in the lymphoma is a T lymphocyte. T cells form a clear majority in MD lymphomas (14, 23, 28) , and, most important, all in vitro propagating cell lines derived from MD lymphomas consist of T lymphoblasts (16, 21) . Also, we have recently obtained evidence that T cells may serve as target cells in MD lymphoma formation (28) . We noted that under experimental conditions, chickens made severely deficient in T-cell population by surgical thymectomy, accompanied by total-body gamma irradiation and repeated injections with antithymocyte serum, developed significantly fewer gross lymphomas than did T-cell-intact hatchmates. B-cell depletion accompanied by agammaglobulinemia had been previously shown to have no effect on MD (11, 18) . Because T cells apparently transform under the influence of MDV, it is of interest that in the present study the effector cells involved in cellmediated immunity in MD were also the T lymphocytes. Assuming that the cytotoxic response to MATSA participates in immune surveillance against MD (19) , it seems somewhat paradoxical that the same cells would be involved in such opposing functions, i.e., target cells for transformation and effector cells for cytotoxicity against the transformed cells.
The apparent functional diversity of T cells in MD may be explained if different subpopulations of T cells are involved. Subpopulations within T cells have been well recognized in certain mammalian systems (5, 15) . Studies by Shiku et al. (31) and by Cantor and Boyse (3, 4) clearly link (11, 18, 26, 29) . On the other hand, immunosuppression in the T-cell functions compromised immune surveillance against MD (30) . Two-month-old chickens ordinarily resistant to MD developed progressive tumors if they were deficient in delayed-type hypersensitivity response because of neonatal thymectomy and total-body gamma irradiation before MDV exposure.
The levels of cytotoxic activity detectable in in vitro cytoxicity tests in MD have been generally quite low, and in the present study I made an effort to enhance cytotoxic levels by treating target and effector cells with VCN. VCN cleaves linkages between sialic acid and mucopolysaccharides on cell surfaces (10) and may alter the immunogenicity of cells by exposing surface antigens that may not be fully expressed because of sialic acid residues (6, 24) . Thus, lymphoid cells treated with VCN become more susceptible to lysis by antibody in vitro (22) and become more antigenic and elicit stronger immune responses in the host than do untreated cells (7, 24) . VCN treatment of effector cells may also enhance their activity by exposing receptor sites that interact with the surface antigens present on target cells (13) . Our results indicated that spleen cells from MDV-infected chickens produced higher specific release of the isotope from VCN-treated MSB-1 target cells than from untreated target cells. Increased cytotoxic activity was specific to MSB-1 cells, and VCN treatment of effector cells was ineffective in altering cytotoxicity. Enhanced sensitivity of the cytotoxicity test by using VCN-treated target cells may be a useful aid in in vitro studies of cell-mediated immunity in MD.
